Annual State of Licensing Survey
Inside the Business of IP Licensing and Commercialization:
LES Foundation Releases its Annual Survey of the Licensing Industry
>>Read the Press Release
Download the March 2009 les Nouvelles article
The LES Foundation is pleased to present the results of its "5th Annual Survey of the Licensing Industry" as published in the March 2009 edition of les Nouvelles.
The Foundation's Annual Survey provides valuable insight and prospective on events and trends impacting the business of licensing. The Survey not only helps licensing professionals better understand and advance the current business environment, but it also gives business and government leaders a greater appreciation for the value and significance of licensing, intellectual asset management and business development.
In the coming years, LES (USA-Canada) will shift its focus to expanding the industry-specific Royalty Rate and Deal Terms Survey initiative. This year the Life Sciences Sector will broaden its survey to include international companies outside of USA and Canada. This is a joint initiative by LES (USA-Canada) Life Science Sector, LESI Life Sciences Sector and international LES societies. This coordinated effort will enhance participation by members and provide leading-edge information through its results.
In addition, the Chemicals, Energy, Environment and Materials (CEEM) Sector will be launching its own Royalty Rate Survey focusing on USA-Canada only.
Both survey instruments are in development and will be circulated to members for their participation in the 4th quarter of 2009. The survey will collect data on deals conducted over the past two years. Preliminary results will be shared at the 2010 Spring Meeting with a final report published July 1, 2010. Additional Survey insights and analysis will be offered through workshops at the 2010 Annual Meeting.
As before, survey responses will be gathered by an independent source and will remain completely confidential. The objective is to provide information to members that is not available from other industry sources. Broad survey participation by LES/LESI members and LES member companies is vital to the success of this innovative effort to bring timely and valuable industry information to members.
For a look at last year's "Biopharmaceutical Royalty Rate and Deal Terms Survey" visit http://www.usa-canada.les.org/press/archives/7.22.08Rates.pdf